All Stories

  1. Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival
  2. The inhibitory effects of capillarisin on cell proliferation and invasion of prostate carcinoma cells
  3. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells
  4. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells
  5. Is diabetes mellitus associated with clinical outcomes in aging males treated with transurethral resection of prostate for bladder outlet obstruction: implications from Taiwan Nationwide Population-Based Cohort Study
  6. MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells
  7. Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells
  8. The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential
  9. MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro
  10. MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential
  11. The Correlation between Chitin and Acidic Mammalian Chitinase in Animal Models of Allergic Asthma
  12. Hepatocellular carcinoma cells express 25(OH)D-1α-hydroxylase and are able to convert 25(OH)D to 1α,25(OH)2D, leading to the 25(OH)D-induced growth inhibition
  13. Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells
  14. PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo
  15. Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells
  16. WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer
  17. Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells
  18. Neoadjuvant hormone therapy following treatment with robotic-assisted radical prostatectomy achieved favorable in high-risk prostate cancer
  19. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma11Equal contributions.
  20. The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial–mesenchymal transition in pancreatic cancer cells
  21. Risk factors associated with ineligibility of adjuvant cisplatin-based chemotherapy after nephroureterectomy
  22. The expression sequence tag is an effective method for screening DNA segments that predict urinary bladder transitional cell carcinoma prognosis
  23. Prostatic urethral angle might be a predictor of treatment efficacy of α-blockers in men with lower urinary tract symptoms
  24. Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways
  25. Chemopreventive and chemotherapeutic effects of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model
  26. Celastrol Blocks Interleukin-6 Gene Expression via Downregulation of NF-κB in Prostate Carcinoma Cells
  27. Topoisomerase Inhibitors Modulate Gene Expression of B-Cell Translocation Gene 2 and Prostate Specific Antigen in Prostate Carcinoma Cells
  28. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro
  29. Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
  30. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase
  31. Reappraisal of the Therapeutic Role of Celecoxib in Cholangiocarcinoma
  32. Metallothionein 3: An androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells
  33. Hypoxia upregulates the gene expression of mitochondrial aconitase in prostate carcinoma cells
  34. Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo
  35. Abstract 2615: 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxy vitaminD 3 (MART-10) is a potent cell growth regulator and tumor metastasis inhibitor in MCF-7 cells: a new emerging strategy against ER+ breast cancer.
  36. Mechanisms by Which Interleukin-6 Attenuates Cell Invasion and Tumorigenesis in Human Bladder Carcinoma Cells
  37. Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells
  38. 1056 PROSTATE-DERIVED ETS FACTOR IS A TUMOR SUPPRESSOR GENE AND ASSOCIATED WITH EPITHELIAL-TO-MESENCHYMAL TRANSITION IN BLADDER CANCER
  39. Glycoprotein transmembrane nmb: An androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells
  40. MART-10, a New Generation of Vitamin D Analog, Is More Potent than 1α,25-Dihydroxyvitamin D3in Inhibiting Cell Proliferation and Inducing Apoptosis in ER+ MCF-7 Breast Cancer Cells
  41. 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells
  42. Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells
  43. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells
  44. p53 downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cells
  45. Cardiac Glycosides Decrease Prostate Specific Antigen Expression by Down-Regulation of Prostate Derived Ets Factor
  46. LUTEOLIN AFFECTS CELL PROLIFERTATION, CELL INVASION AND PROSTATE-SPECIFIC ANTIGEN EXPRESSION BY DYREGULATION OF PROSTATE-DERIVED ETS FACTOR AND ANDROGEN RECEPTOR EXPRESSION IN PROSTATE CARCINOMA LNCAP CELLS
  47. Expression of interleukin-6 is downregulated by 17-(allylamino)-17-demethoxygeldanamycin in human prostatic carcinoma cells
  48. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-Cell translocation gene 2
  49. GROWTH DIFFERENTIATION FACTOR-15 DECREASES TUMORIGENESIS AND INVASION IN PC-3 PROSTATE CARCINOMA CELLS
  50. Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples
  51. Comparisons of voided urine cytology, nuclear matrix protein-22 and bladder tumor associated antigen tests for bladder cancer of geriatric male patients in Taiwan, China
  52. Manganese antagonizes iron blocking mitochondrial aconitase expression in human prostate carcinoma cells
  53. Zinc blocks gene expression of mitochondrial aconitase in human prostatic carcinoma cells
  54. IDENTIFYING THE COMBINATION OF THE TRANSCRIPTIONAL REGULATORY SEQUENCES ON PROSTATE SPECIFIC ANTIGEN AND HUMAN GLANDULAR KALLIKREIN GENES
  55. DOWN-REGULATION OF THE PROSTATE SPECIFIC ANTIGEN PROMOTER BY p53 IN HUMAN PROSTATE CANCER CELLS
  56. Modulation of iron on mitochondrial aconitase expression in human prostatic carcinoma cells
  57. Nitroprusside stimulates mitochondrial aconitase gene expression through the cyclic adenosine 3?,5?-monosphosphate signal transduction pathway in human prostate carcinoma cells
  58. Cyclic adenosine 3′,5′-monosphosphate mediate prolactin regulation of mitochondrial aconitase in human prostate carcinoma cells
  59. Modulation of mitochondrial aconitase on the bioenergy of human prostate carcinoma cells
  60. Protein kinase C activators stimulate betaendorphin secretion from hypothalamic cells
  61. Corticotropin-releasing hormone and dexamethasone do not alter secretion of immunoreactive β-endorphin from dissociated fetal hypothalamic cell cultures